FEMASYS INC (FEMY) - Dilution Analysis

10-K filing | 60.4M shares outstanding

S-3 filing: This is an S-3 filing registering common stock that may be offered by selling stockholders, including shares issuable upon conversion of senior secured convertible notes and exercise of warrants.

S-3/A filing: This SEC filing is an S-3/A form, which is an amendment to a shelf registration statement. It includes exhibits such as the form of underwriting agreement, certificate of incorporation, bylaws, common stock certificate, and forms related to preferred stock, warrants, debt securities, rights certificate, and unit agreement.

10-Q filing | 58.5M shares outstanding

8-K filing: Femasys Inc. entered into a Securities Purchase Agreement to sell convertible notes and warrants to accredited investors in a private placement expected to close in two tranches on November 7, 2025 and November 26, 2025, with gross proceeds of $12 million to be used for debt repayment and working capital.

S-1/A filing: Femasys Inc. is offering up to 11,428,571 shares of common stock, pre-funded warrants, and common warrants, and intends to use the net proceeds for development, general corporate purposes, capital expenditures, and working capital.

10-Q filing | 32.6M shares outstanding

S-3 filing: Femasys Inc. is offering Common Stock, Preferred Stock, and Debt Securities for a total proposed amount of $150,000,000.

8-K filing: Femasys Inc. completed an underwritten public offering of 3,600,000 shares of common stock at $0.85 per share and a concurrent private placement of 1,686,275 shares of common stock at prices of $0.85 and $1.02 per share.

10-Q filing | 25.1M shares outstanding

10-K filing | 27.1M shares outstanding

10-Q filing | 22.2M shares outstanding

10-Q filing | 22.2M shares outstanding

10-Q filing | 21.8M shares outstanding

10-K filing | 22.1M shares outstanding

S-3 filing: This S-3 filing relates to the registration of 18,111,861 shares of common stock offered by selling stockholders, comprised of shares issuable upon conversion of Convertible Notes, exercise of Series A Warrants, and exercise of Series B Warrants.

8-K filing: Femasys Inc. entered into a Securities Purchase Agreement to sell convertible notes and warrants to accredited investors in a private placement expected to close on November 17, 2023, with gross proceeds of $6.85 million. ($13.7M proceeds)

10-Q filing | 21.6M shares outstanding

10-Q filing | 15.1M shares outstanding

S-1 filing: This S-1 filing relates to the registration of 3,388,525 shares of common stock offered by selling stockholders, comprised of shares issuable upon the exercise of Common Warrants and Placement Agent Warrants.

10-Q filing | 11.9M shares outstanding

8-K filing: Femasys Inc. entered into a Securities Purchase Agreement for a registered direct offering and concurrent private placement involving the sale of 1,318,000 shares of common stock and pre-funded warrants to purchase up to 1,878,722 shares, along with warrants to purchase up to 3,196,722 shares, with expected gross proceeds of approximately $3.9 million. ($3.9M proceeds)

10-K filing | 11.8M shares outstanding

10-Q filing | 11.8M shares outstanding

10-Q filing | 11.8M shares outstanding

S-3 filing: Femasys Inc. may offer up to $150,000,000 of any combination of common stock, preferred stock, and debt securities from time to time.

10-Q filing | 11.8M shares outstanding

10-K filing | 11.8M shares outstanding

10-Q filing | 11.8M shares outstanding

10-Q filing | 11.8M shares outstanding

S-1/A filing: Femasys Inc. is offering 2,650,000 shares of common stock in an initial public offering.

S-1 filing: Femasys Inc. is offering shares of its common stock in an initial public offering.